BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28762911)

  • 21. Airway bacterial colonization: the missing link between COPD and cardiovascular events?
    Fuschillo S; Martucci M; Donner CF; Balzano G
    Respir Med; 2012 Jul; 106(7):915-23. PubMed ID: 22546638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic manifestations of COPD.
    Murali Mohan BV; Sen T; Ranganath R
    J Assoc Physicians India; 2012 Feb; 60 Suppl():44-7. PubMed ID: 23155812
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).
    Figueira Gonçalves JM; Dorta Sánchez R; Rodri Guez Pérez MDC; Viña Manrique P; Díaz Pérez D; Guzmán Saenz C; Palmero Tejera JM; Pérez Rodríguez A; Pérez Negrín L
    Clin Investig Arterioscler; 2017; 29(4):149-156. PubMed ID: 28390852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease.
    Rodríguez-Roisin R; Soriano JB
    Proc Am Thorac Soc; 2008 Dec; 5(8):842-7. PubMed ID: 19017739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic effects of chronic obstructive pulmonary disease.
    Agustí AG; Noguera A; Sauleda J; Sala E; Pons J; Busquets X
    Eur Respir J; 2003 Feb; 21(2):347-60. PubMed ID: 12608452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular comorbidity in COPD].
    Cataluña JJ; García MA
    Arch Bronconeumol; 2009; 45 Suppl 4():18-23. PubMed ID: 20116745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.
    Laratta CR; van Eeden S
    Biomed Res Int; 2014; 2014():528789. PubMed ID: 24724085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic consequences of COPD.
    Tkác J; Man SF; Sin DD
    Ther Adv Respir Dis; 2007 Oct; 1(1):47-59. PubMed ID: 19124347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease and cardiovascular disease.
    Bhatt SP; Dransfield MT
    Transl Res; 2013 Oct; 162(4):237-51. PubMed ID: 23727296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects.
    Malerba M; Radaeli A; Nardin M; Clini E; Carpagnano GE; Sciatti E; Salghetti F; Bonadei I; Platto F; Vizzardi E
    Clin Respir J; 2018 Apr; 12(4):1466-1472. PubMed ID: 28779547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pleiotropic Effects of Rosuvastatin in Chronic Obstructive Pulmonary Disease Patients With High Cardiovascular Risk].
    Samorukova EI; Adasheva TV; Zadionchenko VS; Rosliakova GA
    Kardiologiia; 2015; 55(7):32-7. PubMed ID: 26688923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of endothelial function in patients with COPD.
    Clarenbach CF; Senn O; Sievi NA; Camen G; van Gestel AJ; Rossi VA; Puhan MA; Thurnheer R; Russi EW; Kohler M
    Eur Respir J; 2013 Nov; 42(5):1194-204. PubMed ID: 23429917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    MacNee W
    Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial function in patients with chronic obstructive pulmonary disease: a systematic review of studies using flow mediated dilatation.
    Vaes AW; Spruit MA; Theunis J; Goswami N; Vanfleteren LE; Franssen FME; Wouters EFM; De Boever P
    Expert Rev Respir Med; 2017 Dec; 11(12):1021-1031. PubMed ID: 28978239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in COPD: a call for action.
    Bhatt SP; Wells JM; Dransfield MT
    Lancet Respir Med; 2014 Oct; 2(10):783-5. PubMed ID: 25298057
    [No Abstract]   [Full Text] [Related]  

  • 36. Comorbidities and their impact on chronic obstructive pulmonary disease.
    Dursunoğlu N; Köktürk N; Baha A; Bilge AK; Börekçi Ş; Çiftçi F; Gezmen Karadağ M; Çalık Kütükçü E; Noyan A; Polatlı M; Önen ZP; Sarınç S; Umut S; Uzaslan E; Kubat Üzüm A; Akkoca Yıldız Ö;
    Tuberk Toraks; 2016 Dec; 64(4):289-298. PubMed ID: 28393718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk in chronic obstructive pulmonary disease.
    Maclay JD; McAllister DA; Macnee W
    Respirology; 2007 Sep; 12(5):634-41. PubMed ID: 17875049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic obstructive pulmonary disease and cardiovascular diseases--'cardiopulmonary continuum'].
    Batura-Gabryel H; Grabicki M
    Pneumonol Alergol Pol; 2014; 82(6):590-6. PubMed ID: 25339571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives.
    Clarenbach CF; Thurnheer R; Kohler M
    Expert Rev Respir Med; 2012 Feb; 6(1):37-43. PubMed ID: 22283577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular injury and repair in chronic obstructive pulmonary disease.
    Macnee W; Maclay J; McAllister D
    Proc Am Thorac Soc; 2008 Dec; 5(8):824-33. PubMed ID: 19017737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.